Algernon Pharmaceuticals completed its clinical trial agreement with Westchester Research Center at Westchester General Hospital in Miami, Florida, for its multinational Phase IIb/III trial of NP-120 (ifenprodil) for COVID-19. The trial is expected to start after July 20.
The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26 under the ticker PSYK on the NEO Exchange
The biosynthetic platform provides a potential simple and efficient method for rapidly producing natural
The Company’s clinical safety team has actively monitored ongoing interim data of patients and found there have been no safety concerns.....